Kaleido Biosciences Inc (KLDO)
0.00
USD |
OTCM |
Nov 13, 16:00
Kaleido Biosciences Total Assets (Quarterly): 50.14M for Dec. 31, 2021
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 50.14M |
| September 30, 2021 | 67.80M |
| June 30, 2021 | 84.29M |
| March 31, 2021 | 105.03M |
| December 31, 2020 | 59.34M |
| September 30, 2020 | 73.14M |
| June 30, 2020 | 86.98M |
| March 31, 2020 | 66.82M |
| Date | Value |
|---|---|
| December 31, 2019 | 82.31M |
| September 30, 2019 | 91.21M |
| June 30, 2019 | 110.00M |
| March 31, 2019 | 131.27M |
| December 31, 2018 | 85.32M |
| September 30, 2018 | 100.20M |
| December 31, 2017 | 30.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
50.14M
Minimum
Dec 2021
105.03M
Maximum
Mar 2021
75.09M
Average
73.14M
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.53M |
| Shareholders Equity (Quarterly) | 10.61M |